Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) Single-Dose Vial 2 mL (RX)Eribulin Mesylate Injection 1 mg 2 mL (0. 5 mg mL) is an FDA approved, cutting edge antineoplastic agent used in the treatment of metastatic breast cancer and unresectable or metastatic liposarcoma. This single dose, sterile, 2 mL vial delivers precise dosing and reliable administration in hospital, infusion center, and oncology clinic settings. Eribulin Mesylate is a synthetic analog of halichondrin B, proven to extend survival in patients with

FDA and State Troopers

such as a description

the applicator offers optimal control and flexibility

DRV-RTL 5023 - 28”

Malaria: in combination with other drugs for treatment and prevention

It comes in a white

and non-staining for discreet application

It is not only more reliable

Pinch the skin at the injection site to create a fold and insert the needle into the skin at a 90-degree angle

Safety-Lok Feature: Integrated safety shield minimizes the risk of needlestick injuries

Powerful Prescription Topical for Rosacea & Skin Infections

iso-osmotic IV lipid emulsion composed primarily of purified soybean oil